Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Thermo Fisher Scientific Inc (TMO)

Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Nvidia Stock Could Be Just a Few Weeks Away from a Major Downside Catalyst. How to Play NVDA Here.

In October 2025, Goldman Sachs estimated that global AI infrastructure investments could reach $3 to $4 trillion by 2030. Nvidia (NVDA) seems well positioned to benefit from the big market potential, and it’s not surprising that NVDA stock has already created immense value. 

Investors, however, had a phase of anxiety in January 2025 when Nvidia stock plunged by 17%, which translated into a $600 billion loss in market capitalization. This panic was triggered by the launch of DeepSeek, which challenged the dominance of the U.S. in the world of AI. However, the nervousness was short-lived, and U.S. tech stocks have continued to create...

Fundamentals

See More
  • Market Capitalization, $K 231,229,504
  • Shares Outstanding, K 375,708
  • Annual Sales, $ 42,879 M
  • Annual Income, $ 6,335 M
  • EBIT $ 7,509 M
  • EBITDA $ 10,617 M
  • 60-Month Beta 0.91
  • Price/Sales 5.26
  • Price/Cash Flow 20.60
  • Price/Book 4.56

Options Overview Details

View History
  • Implied Volatility 29.37% (-2.62%)
  • Historical Volatility 19.19%
  • IV Percentile 55%
  • IV Rank 24.78%
  • IV High 59.46% on 04/08/25
  • IV Low 19.45% on 01/31/25
  • Expected Move (DTE 3) 9.71 (1.60%)
  • Put/Call Vol Ratio 0.29
  • Today's Volume 2,636
  • Volume Avg (30-Day) 2,787
  • Put/Call OI Ratio 1.42
  • Today's Open Interest 68,649
  • Open Int (30-Day) 68,826
  • Expected Range 597.37 to 616.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 6.43
  • Number of Estimates 11
  • High Estimate 6.48
  • Low Estimate 6.38
  • Prior Year 6.10
  • Growth Rate Est. (year over year) +5.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
554.53 +9.48%
on 12/18/25
628.08 -3.34%
on 01/06/26
+34.80 (+6.08%)
since 12/12/25
3-Month
519.45 +16.87%
on 10/14/25
628.08 -3.34%
on 01/06/26
+82.50 (+15.73%)
since 10/13/25
52-Week
385.46 +57.49%
on 06/18/25
628.08 -3.34%
on 01/06/26
+51.56 (+9.28%)
since 01/13/25

Most Recent Stories

More News
Nvidia Stock Could Be Just a Few Weeks Away from a Major Downside Catalyst. How to Play NVDA Here.

DeepSeek is set to launch its latest V4 model in just a few weeks, drawing parallels to its launch in January 2025 of its R1 model that triggered a selloff in NVDA and other AI names.

NVDA : 185.81 (+0.47%)
TMO : 607.08 (-1.36%)
LLY : 1,077.19 (-0.35%)
Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The effort...

TMO : 607.08 (-1.36%)
Henry Schein Names Frederick M. Lowery as Chief Executive Officer

Industry veteran brings more than 20 years of healthcare distribution experience and operational excellence

HSIC : 75.82 (-0.41%)
TMO : 607.08 (-1.36%)
Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the J.P. Morgan 2026 Healthcare...

TMO : 607.08 (-1.36%)
Thermo Fisher (TMO): Buy, Sell, or Hold Post Q3 Earnings?

Thermo Fisher (TMO): Buy, Sell, or Hold Post Q3 Earnings?

TMO : 607.08 (-1.36%)
What to Expect From Thermo Fisher Scientific's Next Quarterly Earnings Report

Thermo Fisher Scientific will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

XLV : 156.74 (-0.41%)
$SPX : 6,963.74 (-0.19%)
TMO : 607.08 (-1.36%)
3 Low-Volatility Stocks That Fall Short

3 Low-Volatility Stocks That Fall Short

EHC : 100.30 (-2.39%)
TMO : 607.08 (-1.36%)
STEL : 31.58 (-0.13%)
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2025 before the market opens on...

TMO : 607.08 (-1.36%)
Sector Rotation: 2 Smart Money Moves for 2026

Investors are rotating capital into communication services and healthcare stocks as falling interest rates create new opportunities for growth and income.

NFLX : 90.32 (+1.02%)
META : 631.09 (-1.69%)
GOOG : 336.43 (+1.11%)
XLV : 156.74 (-0.41%)
TMO : 607.08 (-1.36%)
LLY : 1,077.19 (-0.35%)
XLC : 116.89 (-0.56%)
UNH : 333.93 (-1.93%)
DIS : 112.98 (+0.14%)
2 S&P 500 Stocks Worth Investigating and 1 We Avoid

2 S&P 500 Stocks Worth Investigating and 1 We Avoid

TMO : 607.08 (-1.36%)
LII : 531.00 (-0.42%)
COIN : 252.69 (+4.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies...

See More

Key Turning Points

3rd Resistance Point 646.02
2nd Resistance Point 633.12
1st Resistance Point 620.10
Last Price 607.08
1st Support Level 594.18
2nd Support Level 581.28
3rd Support Level 568.26

See More

52-Week High 628.08
Last Price 607.08
Fibonacci 61.8% 535.40
Fibonacci 50% 506.77
Fibonacci 38.2% 478.14
52-Week Low 385.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar